The utility of patient specific induced pluripotent stem cells for the modelling of Autistic Spectrum Disorders

Psychopharmacology

Volumn 231, Issue 6, 2014, Pages 1079-1088

  Cocks, Graham ^a   Curran, Sarah ^a   Gami, Priya ^a   Uwanogho, Dafe ^a   Jeffries, Aaron R ^a   Kathuria, Annie ^a   Lucchesi, Walter ^a   Wood, Victoria ^a   Dixon, Rosemary ^a   Ogilvie, Caroline ^b   Steckler, Thomas ^c   Price, Jack ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

Autism; Induced pluripotent stem cells; SHANK3

Indexed keywords

BETA TUBULIN; BRACHYURY PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR NKX2.5; UNCLASSIFIED DRUG;

AUTISM; FIBROBLAST; GENE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; IN VITRO STUDY; KERATINOCYTE; NONHUMAN; PATHOPHYSIOLOGY; PLURIPOTENT STEM CELL; POSTSYNAPTIC DENSITY; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PURKINJE CELL; QUALITY CONTROL; REVIEW; SHANK3 GENE;

ANIMALS; CHILD DEVELOPMENT DISORDERS, PERVASIVE; DISEASE MODELS, ANIMAL; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MODELS, BIOLOGICAL; STEM CELL RESEARCH;

EID: 84896722663     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3196-4     Document Type: Review

References (75)

1. Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, Vassena R, Bilić J, Pekarik V, Tiscornia G, Edel M, Boué S, Izpisúa Belmonte JC (2008) Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26(11):1276-1284
2. Aasen T, Izpisúa Belmonte JC (2010) Isolation and cultivation of human keratinocytes from skin or plucked hair for the generation of induced pluripotent stem cells. Nat Protoc 5(2):371-382
3. Andrews PW, Meyer LJ, Bednarz KL, Harris H (1984) Two monoclonal antibodies recognizing determinants on human embryonal carcinoma cells react specifically with the liver isozyme of human alkaline phosphatase. Hybridoma 3(1):33-39 (Pubitemid 14167480)
4. Anson BD, Kolaja KL, Kamp TJ (2011) Opportunities for use of human iPS cells in predictive toxicology. Clin Pharmacol Ther 89(5):754-758
5. Bailey A, Luthert P, Dean A, Harding B, Janota I, Montgomery M, Rutter M, Lantos P (1998) A clinicopathological study of autism. Brain 121(Pt 5):889-905 (Pubitemid 28220896)
6. Baron-Cohen (2000) The amygdala theory of autism. Neurosci Biobehav Rev 1-10
7. Baudouin SJ, Gaudias J, Gerharz S, Hatstatt L, Zhou K, Punnakkal P, Tanaka KF, Spooren W, Hen R, De Zeeuw CI, Vogt K, Scheiffele P (2012) Shared synaptic pathophysiology in syndromic and nonsyndromic rodentmodels of autism. Science 338(6103):128-132
8. Betancur C (2011) Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res 1380:42-77
9. Bonaglia MC, Giorda R, Borgatti R, Felisari G, Gagliardi C, Selicorni A, Zuffardi O (2001) Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome. Am J Hum Genet 69(2):261-268 (Pubitemid 32695199)
10. Brennand KJ, Simone A, Jou J, Gelboin-Burkhart C, Tran N, Sangar S et al (2011) Modelling schizophrenia using human induced pluripotent stem cells. Nature 1-7
11. Buie, T., Campbell, D.B., Fuchs, G. J., Furuta, G.T., Levy, J., Vande Water, J., et al. (2010). Evaluation, Diagnosis, and Treatment of Gastrointestinal Disorders in Individuals With ASDs: A Consensus Report. Pediatrics, 125(Supplement), S1 S18. doi:10.1542/peds.2009-1878C
12. Buxhoeveden DP, Semendeferi K, Buckwalter J, Schenker N, Switzer R, Courchesne E (2006) Reduced minicolumns in the frontal cortex of patients with autism. Neuropathol Appl Neurobiol 32(5):483-491 (Pubitemid 44401510)
13. Carey BW, Markoulaki S, Hanna J, Saha K, Gao Q, Mitalipova M, Jaenisch R (2009) Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci U S A 106(1):157-162
14. Carper RA, Moses P, Tigue ZD, Courchesne E (2002) Cerebral lobes in autism: early hyperplasia and abnormal age effects. NeuroImage 16(4):1038-1051
15. Casanova MF, Buxhoeveden DP, Switala AE, Roy E (2002) Minicolumnar pathology in autism. Neurology 58(3):428-432 (Pubitemid 34150918)
16. Casanova MF, El-Baz A, Vanbogaert E, Narahari P, Switala A (2010) A topographic study of minicolumnar core width by lamina comparison between autistic subjects and controls: possible minicolumnar disruption due to an anatomical element in-common to multiple laminae. Brain Pathol 20(2):451-458
17. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L (2009) Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 27(3):275-280
18. Chan EM, Ratanasirintrawoot S, Park IH, Manos PD, Loh YH, Huo H, Miller JD, Hartung O, Rho J, Ince TA, Daley GQ, SchlaegerTM(2009) Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat Biotechnol 27(11):1033-1037
19. Courchesne E, Karns CM, Davis HR, Ziccardi R, Carper RA, Tigue ZD, Chisum HJ, Moses P, Pierce K, Lord C, Lincoln AJ, Pizzo S, Schreibman L, Haas RH, Akshoomoff NA, Courchesne RY (2001) Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology 57(2):245-254 (Pubitemid 32667357)
20. Crawley JN (2012) Translational animal models of autism and neurodevelopmental disorders. Dialogues Clin Neurosci 14(3):293-305
21. Daley GQ, Lensch MW, Jaenisch R, Meissner A, Plath K, Yamanaka S (2009) Broader implications of defining standards for the pluripotency of iPSCs. Cell Stem Cell 4(3):200-201
22. Devlin B, Scherer SW (2012) Genetic architecture in autism spectrum disorder. Curr Opin Genet Dev 22(3):229-237
23. Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F, Nygren G, Rastam M, Gillberg IC, Anckarsäter H, Sponheim E, Goubran-Botros H, Delorme R, Chabane N, Mouren-Simeoni MC, de Mas P, Bieth E, Rogé B, Héron D, Burglen L, Gillberg C, Leboyer M, Bourgeron T (2007) Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. NatGenet 39(1):25-27 (Pubitemid 46026497)
24. Durand CM, Perroy J, Loll F, Perrais D, Fagni L, Bourgeron T, Montcouquiol M, Sans N (2012) SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism. Mol Psychiatry 17(1):71-84
25. Eglen R, Reisine T (2011) Primary cells and stem cells in drug discovery: emerging tools for high-throughput screening. Assay Drug Dev Technol 9(2):108-124
26. Ebert DH, Greenberg ME (2013) Activity-dependent neuronal signalling and autism spectrum disorder. Nature 493(7432):327-337
27. Eiraku M, Watanabe K, Matsuo-Takasaki M, Kawada M, Yonemura S, Matsumura M, Wataya T, Nishiyama A, Muguruma K, Sasai Y (2008) Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals. Cell Stem Cell 3(5):519-532
28. Hampson DR, Gholizadeh S, Pacey LK (2012) Pathways to drug development for autism spectrum disorders. Clin Pharmacol Ther 91(2):189-200
29. Hayashi MK, Tang C, Verpelli C, Narayanan R, Stearns MH, Xu RM, Li H, Sala C, Hayashi Y (2009) The postsynaptic density proteins Homer and Shank form a polymeric network structure. Cell 137(1):159-171
30. Hennings H, Michael D, Cheng C, Steinert P, Holbrook K, Yuspa SH (1980) Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 19(1):245-254 (Pubitemid 10154229)
31. Huett A, Leong JM, Podolsky DK, Xavier RJ (2009) Thecytoskeletal scaffold Shank3 is recruited to pathogen-induced actin rearrangements. Exp Cell Res 315(12):2001-2011
32. Jeffries AR, Curran S, Elmslie F, Sharma A, Wenger S, Hummel M, Powell J (2005) Molecular and phenotypic characterization of ring chromosome 22. Am J Med Genet A 137(2):139-147 (Pubitemid 41262680)
33. Jiang YH, Ehlers MD (2013) Modelling autism by SHANK gene mutations in mice. Neuron 78(1):8-27
34. Krueger DD, Bear MF (2011) Toward fulfilling the promise of molecular medicine in fragile X syndrome. Annu Rev Med 62:411-429
35. Lord C, Rutter M, Goode S, Heemsbergen J, Jordan H, Mawhood L, Schopler E (1989) Autism diagnostic observation schedule: a standardized observation of communicative and social behavior. J Autism Dev Disord 19(2):185-212 (Pubitemid 19176529)
36. Lord C, Rutter M, Le Couteur A (1994) Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24(5):659-685 (Pubitemid 24309810)
37. Maherali N, Hochedlinger K (2008) Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 3(6):595-605
38. Marchetto MC, Gage FH (2012) Modelling brain disease in a dish: really? Cell Stem Cell 10(6):642-645
39. Markou A, Chiamulera C, Geyer MA, Tricklebank M, Steckler T (2009) Removing obstacles in neuroscience drug discovery: the future path for animal models. Neuropsychopharmacology 34(1):74-89
40. Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, D'Souza C, Fouse SD, Johnson BE, Hong C, Nielsen C, Zhao Y, Turecki G, Delaney A, Varhol R, Thiessen N, Shchors K, Heine VM, Rowitch DH, Xing X, Fiore C, Schillebeeckx M, Jones SJ, Haussler D, Marra MA, Hirst M, Wang T, Costello JF (2010) Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 466(7303):253-257
41. McAllister AK, Patterson PH (2012) Introduction to special issue on neuroimmunology in brain development and disease. Dev Neurobiol 72(10):1269-1271
42. Muguruma K, Nishiyama A, Ono Y, Miyawaki H, Mizuhara E, Hori S, Kakizuka A, Obata K, Yanagawa Y, Hirano T, Sasai Y (2010) Ontogeny-recapitulating generation and tissue integration of ES cell-derived Purkinje cells. Nat Neurosci 13(10):1171-1180
43. Müller FJ, Goldmann J, Löser P, Loring JF (2010) A call to standardize teratoma assays used to define human pluripotent cell lines. Cell Stem Cell 6(5):412-414
44. Müller FJ, Schuldt BM, Williams R, Mason D, Altun G, Papapetrou EP, Danner S, Goldmann JE, Herbst A, Schmidt NO, Aldenhoff JB, Laurent LC, Loring JF (2011)Abioinformatic assay for pluripotency in human cells. Nat Methods 8(4):315-317
45. Nasu M, Takata N, Danjo T, Sakaguchi H, Kadoshima T, Futaki S, Sekiguchi K, Eiraku M, Sasai Y (2012) Robust formation and maintenance of continuous stratified cortical neuroepithelium by laminin-containing matrix in mouse ES cell culture. PLoS One 7(12):e53024
46. Nightingale S (2012) Autism spectrum disorders. Nat Rev Drug Discov 11(10):745-746
47. Nishimura K, Sano M, Ohtaka M, Furuta B, Umemura Y, Nakajima Y et al (2011) Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming. J Biol Chem 286(6):4760-4771
48. Palmen SJ, van Engeland H, Hof PR, Schmitz C (2004) Neuropathological findings in autism. Brain 127(Pt 12):2572-2583 (Pubitemid 39627367)
49. Pankratz MT, Li XJ, Lavaute TM, Lyons EA, Chen X, Zhang SC (2007) Directed neural differentiation of human embryonic stem cells via an obligated primitive anterior stage. Stem Cells 25(6):1511-1520 (Pubitemid 47106020)
50. Papapetrou EP, Sadelain M (2011) Generation of transgene-free human induced pluripotent stem cells with an excisable single polycistronic vector. Nat Protoc 6(9):1251-1273
51. Paşca SP, Portmann T, Voineagu I, Yazawa M, Shcheglovitov A, Paşca AM et al (2011) Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nat Publ Group 17(12):1657-1662
52. Phelan K, McDermid HE (2012) The 22q13.3 deletion syndrome (Phelan-McDermid syndrome). Mol Syndromol 2(3-5):186-201
53. Redcay E, Courchesne E (2005) When is the brain enlarged in autism? A meta-analysis of all brain size reports. Biol Psychiatry 58(1):1-9 (Pubitemid 40909929)
54. Redecker P, Bockmann J, Böckers TM (2006) Expression of postsynaptic density proteins of the ProSAP/Shank family in the thymus. Histochem Cell Biol 126(6):679-685 (Pubitemid 44899711)
55. Ritvo ER, Freeman BJ, Scheibel AB, Duong T, Robinson H, Guthrie D, Ritvo A (1986) Lower Purkinje cell counts in the cerebella of four autistic subjects: initial findings of the UCLA-NSAC Autopsy Research Report. Am J Psychiatry 143(7):862-866 (Pubitemid 16090391)
56. Roullet FI, Lai JK, Foster JA. In utero exposure to valproic acid and autism-A current review of clinical and animal studies. Neurotoxicol Teratol. 2013 Feb 8 [Epub ahead of print]
57. Roussignol G, Ango F, Romorini S, Tu JC, Sala C, Worley PF, Bockaert J, Fagni L (2005) Shank expression is sufficient to induce functional dendritic spine synapses in aspiny neurons. J Neurosci 25(14):3560-3570
58. Sasai Y (2013) Cytosystems dynamics in self-organization of tissue architecture. Nature 493(7432):318-326
59. Shi Y, Kirwan P, Smith J, Robinson HP, Livesey FJ (2012) Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses. Nat Neurosci 15(3):477-486
60. Sparks BF, Friedman SD, Shaw DW, Aylward EH, Echelard D, Artru AA, Maravilla KR, Giedd JN, Munson J, Dawson G, Dager SR (2002) Brain structural abnormalities in young children with autism spectrum disorder. Neurology 59(2):184-192 (Pubitemid 34779175)
61. St John JC, Armstrong L, Minger SL, Campbell KH (2008) Law should recognize value of interspecies embryos. Nature 451(7179):627 (Pubitemid 351220543)
62. Su HL, Muguruma K, Matsuo-Takasaki M, Kengaku M, Watanabe K, Sasai Y (2006) Generation of cerebellar neuron precursors from embryonic stem cells. Dev Biol 290(2):287-296 (Pubitemid 43163492)
63. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663-676 (Pubitemid 44233629)
64. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861-872 (Pubitemid 350138099)
65. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145-1147 (Pubitemid 28516247)
66. van der Worp HB, Howells DW, Sena ES, Porritt MJ, Rewell S, O'Collins V, Macleod MR (2010) Can animal models of disease reliably inform human studies? PLoS Med 30:7(3)
67. Verpelli C, Schmeisser MJ, Sala C, Boeckers TM (2012) Scaffold proteins at the postsynaptic density. Adv Exp Med Biol 970:29-61
68. Verpelli C, Dvoretskova E, Vicidomini C, Rossi F, Chiappalone M, Schoen M, Di Stefano B, Mantegazza R, Broccoli V, Böckers TM, Dityatev A, Sala C (2011) Importance of Shank3 protein in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses. J Biol Chem 286(40):34839-34850
69. Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner A, Daley GQ, Brack AS, Collins JJ, Cowan C, Schlaeger TM, Rossi DJ (2010) Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7(5):618-630
70. Whitney ER, Kemper TL, Bauman ML, Rosene DL, Blatt GJ (2008) Cerebellar Purkinje cells are reduced in a subpopulation of autistic brains: a stereological experiment using calbindin-D28k. Cerebellum 7(3):406-416
71. Wilson HL, Wong AC, Shaw SR, Tse WY, Stapleton GA, Phelan MC, Hu S, Marshall J, McDermid HE (2003) Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J Med Genet 40(8):575-584 (Pubitemid 37046910)
72. Yang YM (2013) A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. Cell Stem Cell S1934-5909(13):00139-2. doi:10.1016/j.stem.2013.04.003
73. Ye Z, Zhan H, Mali P, Dowey S, Williams DM, Jang YY, Dang CV, Spivak JL, Moliterno AR, Cheng L (2009) Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 114(27):5473-5480
74. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science 324(5928):797-801
75. Zhu S, Li W, Zhou H, Wei W, Ambasudhan R, Lin T, Kim J, Zhang K, Ding S (2010) Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell 7(6):651-655